| The candidate tumor suppressor gene NORE1B is epigenetically down-regulated in hepatocellular carcinoma. | liver, |
| Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma. | neuroblastoma, |
| RASSF5 expression is negatively correlated with distant metastasis of osteosarcoma, and RASSF5 may function as a tumor suppressor in OS cells through activation of the MST1/LATS1 pathway. | osteosarcoma, |
| the inactivation of RASSF5A through CpG island 1 methylation may play an important role in esophageal squamous cell carcinoma (ESCC) carcinogenesis, RASSF5A may be a functional tumor suppressor and may serve as a prognostic biomarker for ESCC. | esophageal, |
| Nore1 is a member of a family of Ras effector/tumor suppressors that includes RASSF1 | None |
| The growth and tumor suppressor NORE1A is a cytoskeletal protein that suppresses growth by inhibition of the ERK pathway. | None |
| Nuclear transport of Ras-associated tumor suppressor proteins: different transport receptor binding specificities for arginine-rich nuclear targeting signals. | None |
| NORE1B suppresses replication and transformation of cells as effectively as RASSF1A and is a putative tumor suppressor gene. NORE1B interacts with RASSF1A and loss of one of these may lead to uncontrolled growth and transformation of hepatocytes. | None |
| a novel regulatory network composed of the tumor suppressor NORE1A, the mitotic kinase Aurora A, the small GTPase Ras, and the microtubule cytoskeleton. | None |
| a direct role for RASSF5 in death receptor ligand-mediated apoptosis and provide further evidence for RASSF5 as a tumor suppressor. | None |
| RASSF5: An MST activator and tumor suppressor in vivo but opposite in vitro | None |
| Nonstructural protein 5B promotes degradation of the NORE1A tumor suppressor to facilitate hepatitis C virus replication | None |
| The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence | None |
| Tumor suppressor C-RASSF proteins | None |